Targeted Genetics Corp., of Seattle named James Johnson vicepresident and chief financial officer.Biodevelopment Laboratories, of Cambridge, Mass., named HenryEsber vice president of marketing.The Massachusetts Biotechnology Council, of Cambridge, namedAlison Taunton-Rigby president.American Science & Engineering, of Cambridge, Mass., named PeterHarris vice president, sales and marketing.Middlesex Sciences Inc., of Foxborough, Mass., named Spiros Jamasto the board of directors.Signal Pharmaceuticals Inc., of San Diego, appointed David Andersonto vice president of drug discovery/development and JacquelineJohnson to vice president of operations.Cellcor Inc., of Newton, Mass., named Harry Wilcox III vice president,business development and chief financial officer.Sonus Pharmaceuticals, of Costa Mesa, Calif., named Tery Willardvice president of marketing and business development.Neoprobe Corp., of Columbus, Ohio, named Hazle Shorter vicepresident, clinical research, and William Eisenhardt vice president,research and development.InnoVet Inc., of West Palm Beach, Fla., promoted Daniel Walker tovice president, business development.Denmark-based biotechnology group Novo Nordisk A/S appointedHenrik Aagaard president of Novo Nordisk of North America.Biomune Systems Inc., of Salt Lake City, appointed Allan Barker andThomas Garvey III to its board of directors.Glyko Biomedical Ltd., of Novato, Calif., said John Dorson joined thecompany as vice president and general manager-analytic business.Shaman Pharmaceuticals Inc., of South San Francisco, Calif., said KurtAmundson joined the company as vice president and chief financialofficer.InVitro International, of Irvine, Calif., elected Jeffrey Safchik to itsboard of directors.Argus Pharmaceuticals, of Houston appointed Gillian Ivers-Read asvice president of regulatory affairs.Genelabs Technologies Inc., of Redwood City, Calif., appointedDouglas Lee as vice president and chief financial officer.Atrix Laboratories Inc., of Fort Collins, Colo., appointed WilliamO'Neil Jr. as chairman of the board of directors.Innovex Diagnostics Inc., of San Diego, hired Jeff Anderman as chieffinancial officer.Microcide Pharmaceuticals Inc., of Mountain View, Calif., named VingLee to the position of president-chemistry and preclinical evaluation.The ICN Pharmaceutical group, of Costa Mesa, Calif., appointed MarkTaylor vice president-investor relations.Xoma Corp., of Berkeley, Calif., named Peter David vice president,finance and chief financial officer.041294APPOINTMENTS

(c) 1997 American Health Consultants. All rights reserved.